MedPath

Blood Flow Restricted Electrical Stimulation During Immobilisation

Not Applicable
Conditions
Atrophy, Disuse
Atrophy, Muscular
Interventions
Other: Neuromuscular electrical stimulation with blood flow restriction
Registration Number
NCT05093985
Lead Sponsor
St Mary's University College
Brief Summary

Following injury or surgery to a limb, it is often immobilised to allow tissue healing. Short periods of disuse cause loss of muscle size and strength and impaired mechanical properties of tendons, which leads to reduced function. Strategies to combat these deconditioning adaptations include neuromuscular electrical stimulation (NMES), however at present its effectiveness is limited. Recent research suggests that the effects of NMES can be augmented with blood flow restriction (BFR). At present, the effect of combining these two techniques on muscle function during limb immobilisation is unknown. Furthermore, the impact of BFR training during retraining following immobilisation is unknown.

Detailed Description

Following injury or surgery to a limb, it is often immobilised to allow tissue healing. Short periods of disuse cause loss of muscle size and strength and impaired mechanical properties of tendons, which leads to reduced function. Strategies to combat these deconditioning adaptations include neuromuscular electrical stimulation (NMES), however at present its effectiveness is limited. Recent research suggests that the effects of NMES can be augmented with blood flow restriction (BFR). At present, the effect of combining these two techniques on muscle function during limb immobilisation is unknown. Furthermore, the impact of BFR training during retraining following immobilisation is unknown.

This study will examine the effectiveness and feasibility of a neuromuscular electrical stimulation and blood flow restriction protocol during a 7 day period of immobilisation. Multiple measures across several physiological systems will be obtained.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
36
Inclusion Criteria
  • Between the age of 18-55
  • Non-smoker
  • No previous history of cardiovascular, respiratory or neurological problems
  • Not taking anticoagulant medication
  • Injury-free in the 3 months prior to scheduled participation in the study.
Exclusion Criteria
  • Hypertension (<140/80)
  • Metal work in-situ
  • Blood diseases or clotting issues
  • Injury or previous injury (<3 months prior to scheduled participation in the study)
  • Pregnancy

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Neuromuscular electrical stimulation with blood flow restrictionNeuromuscular electrical stimulation with blood flow restrictionThis is the intervention condition
Primary Outcome Measures
NameTimeMethod
Change in maximal isometric strength via Biodex DynamometerThrough study completion, an average of 1 year

Strength measure

Change in maximal isokinetic strength via Biodex DynamometerThrough study completion, an average of 1 year

Strength measure

Secondary Outcome Measures
NameTimeMethod
Change in muscle VO2 via near-infrared spectroscopyThrough study completion, an average of 1 year

VO2 measure

Change in blood markers via venous blood samplesThrough study completion, an average of 1 year

Blood markers

Change in muscle endurance via Biodex DynamometerThrough study completion, an average of 1 year

Endurance measure

Change in muscle morphology via 2D and 3D ultrasonographyThrough study completion, an average of 1 year

Morphology measure

Change in pressure pain thresholds via handheld allometryThrough study completion, an average of 1 year

Pain measure

Change in corticomotor excitability and inhibition, via transcranial magnetic stimulationThrough study completion, an average of 1 year

Corticospinal function

© Copyright 2025. All Rights Reserved by MedPath